Reply: Interleukin-18 Inhibition in Inflammatory Bowel Diseases: A Delicate Balance
Inflammatory Bowel Diseases · 03.04.2024 · 30 (4) · 695-696
DOI: 10.1093/ibd/izae039 ↗Kurz gefasst
Leserbrief in der Zeitschrift Inflammatory Bowel Diseases, online erschienen am 05.03.2024. Verfasst von Keiko Maeda und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases, Colitis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan.
ORCID-Profile: Keiko Maeda
Zitieren
APA
Maeda, K., & Kawashima, H. (2024). Reply: Interleukin-18 Inhibition in Inflammatory Bowel Diseases: A Delicate Balance. Inflammatory Bowel Diseases, 30(4), 695-696. https://doi.org/10.1093/ibd/izae039
Vancouver
Maeda K, Kawashima H. Reply: Interleukin-18 Inhibition in Inflammatory Bowel Diseases: A Delicate Balance. Inflammatory Bowel Diseases. 2024;30(4):695-696. doi:10.1093/ibd/izae039
BibTeX
@article{Maeda2024,
author = {Maeda, Keiko and Kawashima, Hiroki},
title = {Reply: Interleukin-18 Inhibition in Inflammatory Bowel Diseases: A Delicate Balance},
journal = {Inflammatory Bowel Diseases},
year = {2024},
volume = {30},
number = {4},
pages = {695--696},
doi = {10.1093/ibd/izae039}
}
EUVIMED